XERIS PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for XERIS PHARMACEUTICALS INC NOTE 5.000% 7/1, CUSIP 98422LAA5.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for XERIS PHARMACEUTICALS INC NOTE 5.000% 7/1, CUSIP 98422LAA5.